Scarica l'app Stockscreener
16.55
0.06%
-0.010
Dopo l'orario di chiusura:
16.55
Bausch Lomb Corp Borsa (BLCO) Ultime notizie
Bausch + Lomb survey finds dry eye symptoms linked to emotional health impacts - Optometry Times
Dry eye treatment tied to lower anxiety, better confidence in Bausch + Lomb survey - Stock Titan
Bausch + Lomb Corp updates investors on strategic focus, shares trade on NYSE - AD HOC NEWS
INFUSE silicone hydrogel daily contact lenses from Bausch + Lomb Corp.a moisture-first take on al - AD HOC NEWS
BLCO Forecast — Price Target — Prediction for 2027 - TradingView
S2L Forecast — Price Target — Prediction for 2027 - TradingView
Bausch + Lomb Corporation Actuals & Estimates (NYSE:BLCO) - TradingView
Bausch + Lomb Corporation Actuals & Estimates (TSX:BLCO) - TradingView
Bausch + Lomb Tumbles as Technical and Governance Fears Mount - TipRanks
(BLCO) Risk Channels and Responsive Allocation - Stock Traders Daily
INFUSE Multifocal from Bausch + Lomb Corp.daily disposable lens for presbyopia - AD HOC NEWS
Cooper Cos. gains after report activist Jana takes stake - MSN
Bausch + Lomb (BLCO) Consolidates Near Support Following Minimal Daily ChangeFloat Adjusted Cap - dars.gov.et
Bausch + Lomb Corp (BLCO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bausch + Lomb Corp (BLCO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Bausch + Lomb Corp (BLCO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bausch + Lomb Corp (BLCO) Institutional Confidence - TradingKey
Bausch + Lomb Corp (BLCO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bausch + Lomb Corp (BLCO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bausch + Lomb Corp (BLCO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bausch + Lomb Corp (BLCO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bausch + Lomb Corp (BLCO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Bausch & Lomb (NYSE: BLCO) executive has 1,008 shares withheld for tax on RSU vesting - Stock Titan
Emmetrope Ophthalmics LLC announced that it has received funding from Bausch + Lomb Corporation - marketscreener.com
Bausch + Lomb Corporation (BLCO): Investor Outlook With An 18.53% Potential Upside - DirectorsTalk Interviews
(BLCO) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Bausch + Lomb to lay off employees in Missouri - Yahoo Finance
Transcript : Bausch + Lomb Corporation Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 01 - marketscreener.com
Bausch + Lomb Dry Eye Launch Highlights Valuation Gap And Growth Questions - Yahoo Finance
Why Bausch + Lomb Corp stock is sliding today - Wealth Awesome
Bausch + Lomb Corporation (BLCO): Investor Outlook and Potential 15.62% Upside in the Healthcare Sector - DirectorsTalk Interviews
Assessing Bausch + Lomb (NYSE:BLCO) Valuation After Blink Triple Care Preservative Free U.S. Launch - Sahm
Will Blink Triple Care’s Preservative Free Launch Reshape Bausch + Lomb’s (BLCO) Consumer Eye Care Narrative? - webull.com
Bausch + Lomb’s New Dry Eye Launch And What It Means For BLCO - Sahm
RBC Capital reiterates Bausch & Lomb stock rating at Outperform By Investing.com - Investing.com Australia
RBC Capital reiterates Bausch & Lomb stock rating at Outperform - Investing.com
Bausch + Lomb Corp stock (CA07174N1090): valuation metrics in focus after recent trading in Toronto - AD HOC NEWS
Bausch + Lomb Insiders Added US$2.46m Of Stock To Their Holdings - Moomoo
Liquidity Mapping Around (BLCO) Price Events - Stock Traders Daily
Bausch + Lomb (BLCO) R&D Day 2026 Summary - Quartr
BLCO.CA Stock Price, Quote & Chart | BAUSCH + LOMB CORP (TSX:BLCO) - ChartMill
Bausch + Lomb launches preservative-free dry eye drops in U.S. By Investing.com - Investing.com South Africa
Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States - BioSpace
Preservative-free eye drops offer up to 10 hours dry-eye relief - Stock Titan
Bausch + Lomb Corporation (BLCO) Investor Outlook: Analyzing Growth Potential with a 14% Upside - DirectorsTalk Interviews
BLCO Stock Price, Quote & Chart | BAUSCH + LOMB CORP (NYSE:BLCO) - ChartMill
Bausch & Lomb (BLCO) director awarded 15,842 RSUs under 2022 Omnibus Incentive Plan - Stock Titan
Bausch & Lomb (NYSE: BLCO) grants 15,842 RSUs to director - Stock Titan
Bausch & Lomb (NYSE: BLCO) director awarded 15,842-share RSU grant - Stock Titan
Bausch & Lomb (BLCO) director John Paulson receives 15,842-share RSU grant - Stock Titan
Bausch & Lomb (BLCO) director Karen Ling awarded 15,842 RSUs as annual equity grant - Stock Titan
Director at Bausch & Lomb (NYSE: BLCO) gets 15,842-share RSU award - Stock Titan
Bausch & Lomb Corp (BLCO) awards 15,842 RSUs to director Collis - Stock Titan
Bausch & Lomb (BLCO) director granted 15,842 RSUs in annual equity award - Stock Titan
Bausch & Lomb (NYSE: BLCO) director receives 15,842-share RSU grant - Stock Titan
Bausch + Lomb Lifts 2026 Guidance, 1Q Loss Narrows - Moomoo
Bausch & Lomb (NYSE: BLCO) CEO reports 2,886-share tax withholding on RSU vesting - Stock Titan
Bausch + Lomb: Even Though Growth Continues, I Don't See A Way Higher (NYSE:BLCO) - Seeking Alpha
Evercore ISI Group Maintains Bausch + Lomb (BLCO) Outperform Recommendation - MSN
1.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):